Safety of macrolides during pregnancy

American Journal of Obstetrics and Gynecology

Volumn 208, Issue 3, 2013, Pages 221.e1-221.e8

  Lin, Kueiyu Joshua ^a   Mitchell, Allen A ^b   Yau, Wai Ping ^a,c   Louik, Carol ^b   Hernández Díaz, Sonia ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b BOSTON UNIVERSITY   (United States)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

azithromycin; clarithromycin; congenital malformations; erythromycin; macrolides

Indexed keywords

ERYTHROMYCIN; MACROLIDE; PENICILLIN DERIVATIVE;

ARTICLE; CONFIDENCE INTERVAL; CONGENITAL HEART MALFORMATION; CONTROLLED STUDY; DRUG SAFETY; FEMALE; FETUS; FEVER; FIRST TRIMESTER PREGNANCY; HUMAN; INFANT; INFECTION; MAJOR CLINICAL STUDY; PREGNANCY; PRIORITY JOURNAL; PYLORUS STENOSIS; RISK FACTOR; SENSITIVITY ANALYSIS; THIRD TRIMESTER PREGNANCY;

EID: 84874773681     PISSN: 00029378     EISSN: 10976868     Source Type: Journal    
DOI: 10.1016/j.ajog.2012.12.023     Document Type: Article

References (16)

1. Centers for Disease Control and Prevention 1998 Guidelines for treatment of sexually transmitted diseases MMWR Recomm Rep 47 1998 1 111
2. A.A. Mitchell, S.M. Gilboa, M.M. Werler, K.E. Kelley, C. Louik, S. Hernandez-Diaz Medication use during pregnancy, with particular focus on prescription drugs: 1976-2008 Am J Obstet Gynecol 205 2011 51.e1 51.e8
3. K.S. Crider, M.A. Cleves, J. Reefhuis, R.J. Berry, C.A. Hobbs, D.J. Hu Antibacterial medication use during pregnancy and risk of birth defects: national birth defects prevention study Arch Pediatr Adolesc Med 163 2009 978 985
4. J.O. Klein History of macrolide use in pediatrics Pediatr Infect Dis J 16 1997 427 431
5. B.A. Kallen, P. Otterblad Olausson, B.R. Danielsson Is erythromycin therapy teratogenic in humans? Reprod Toxicol 20 2005 209 214
6. W.O. Cooper, S. Hernandez-Diaz, P.G. Arbogast Antibiotics potentially used in response to bioterrorism and the risk of major congenital malformations Paediatr Perinat Epidemiol 23 2009 18 28
7. M.A. Honein, L.J. Paulozzi, I.M. Himelright Infantile hypertrophic pyloric stenosis after pertussis prophylaxis with erythromycin: a case review and cohort study Lancet 354 1999 2101 2105
8. B.E. Mahon, M.B. Rosenman, M.B. Kleiman Maternal and infant use of erythromycin and other macrolide antibiotics as risk factors for infantile hypertrophic pyloric stenosis J Pediatr 139 2001 380 384
9. W.O. Cooper, W.A. Ray, M.R. Griffin Prenatal prescription of macrolide antibiotics and infantile hypertrophic pyloric stenosis Obstet Gynecol 100 2002 101 106
10. C. Louik, M.M. Werler, A.A. Mitchell Erythromycin use during pregnancy in relation to pyloric stenosis Am J Obstet Gynecol 186 2002 288 290
11. C. Louik, A.A. Mitchell Prenatal prescription of macrolide antibiotics and infantile hypertrophic pyloric stenosis Obstet Gynecol 101 2003 816 817
12. A.A. Mitchell, L. Rosenberg, S. Shapiro, D. Slone Birth defects related to Bendectin use in pregnancy, I: oral clefts and cardiac defects JAMA 245 1981 2311 2314
13. A.A. Mitchell, L.B. Cottler, S. Shapiro Effect of questionnaire design on recall of drug exposure in pregnancy Am J Epidemiol 123 1986 670 676
14. W.P. Yau, K.J. Lin, M.M. Werler, C. Louik, A.A. Mitchell, S. Hernandez-Diaz Drug certainty-response in interview-based studies Pharmacoepidemiol Drug Saf 20 2011 1210 1216
15. T. Peeters, G. Matthijs, I. Depoortere, T. Cachet, J. Hoogmartens, G. Vantrappen Erythromycin is a motilin receptor agonist Am J Physiol 257 1989 G470 G474
16. M. Romoren, M. Lindbaek, H. Nordeng Pregnancy outcome after gestational exposure to erythromycin-a population-based register study from Norway Br J Clin Pharmacol 74 2012 1053 1062